← Leaderboards
Helen M Leonard
University Of Western Australia
$2,011,110
Attributed
$5,531,371
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,531,371 · 2
By mechanism
U01$4,693,682 · 1
R01$837,689 · 1
Top collaborators
- Timothy A Benke7 shared
- Jenny Downs7 shared
- Eric D Marsh7 shared
Others in their field
Top investigators on “Rett Syndrome”
- Jack L. Feldman · University Of California Los Angeles$18,884,440
- Janine M Lasalle · University Of California At Davis$14,699,095
- Michael E Greenberg · Dana-Farber Cancer Institute$10,814,575
- Alysson R. Muotri · University Of California, San Diego$8,271,815
- Russell S Ray · Baylor College Of Medicine$8,219,318
- Alan Kenneth Percy · University Of Alabama At Birmingham$7,489,645
Research focus
Rett SyndromeSymptomsEpilepsyGeneticElectroencephalographyQuality Of LifeSiteImpaired CognitionMotor ImpairmentMulti-Institutional Clinical TrialEvoked PotentialsEpileptic EncephalopathiesBiological MarkersBiomarker ValidationMeasurementAnimal ModelModificationGenesClinical Outcome MeasuresClinical Trial ReadinessGene TherapyClinical TrialsCyclin-Dependent KinasesClinical Research
Grant awards (12)
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$782,432
U01 · FY2025 · NS
Multi-site validation of biomarkers and core clinical outcome measures for clinical trial readiness in CDKL5 Deficiency Disorder - Supplement$77,998
U01 · FY2025 · NS
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$859,629
U01 · FY2024 · NS
Multi-site validation of biomarkers and core clinical outcome measures for clinical trial readiness in CDKL5 Deficiency Disorder$78,000
U01 · FY2024 · NS
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$902,257
U01 · FY2023 · NS
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$924,239
U01 · FY2022 · NS
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$1,069,127
U01 · FY2021 · NS
Rett syndrome: determinants of outcome and burden$161,286
R01 · FY2007 · HD · contact PI
Rett syndrome: determinants of outcome and burden$166,103
R01 · FY2006 · HD · contact PI
Rett syndrome: determinants of outcome and burden$170,100
R01 · FY2005 · HD
Rett syndrome: determinants of outcome and burden$170,100
R01 · FY2004 · HD
Rett syndrome: determinants of outcome and burden$170,100
R01 · FY2003 · HD